India expected to unveil two government developed varieties of GMO cotton

Screen Shot at PM
Photo by Jud McCranie/Wikimedia

India is expected to unveil in November two . . . cotton varieties that will cost less than other hybrids but give higher yields, as well as resist whitefly, pink bollworm and leaf curl virus that often damage the crop in the country. These seeds, which will compete with US multinational Monsanto’s Bollgard II, will likely be distributed to farmers starting next year.

The long-staple local or desi seeds and short-duration American cotton varieties were developed by the Central Institute for Cotton Research (CICR) in Nagpur. . . .

The cost of the 14 long-staple desi varieties is half that of Bt cotton hybrid. . . The output will be similar or more than the Bt cotton hybrid . . . while the fibre quality will be similar, [CICR Director KR Kranthi said.]

The desi varieties will offer better pest resistance. . . .

In the American cotton, . . . seeds can be reused by farmers and will cost Rs 150-200 kg compared with Rs 2,000 for the Bt-cotton hybrid, Kranthi said.

. . . .

Indigenously developed genetically modified cotton seeds could change the complexion of the market. It will provide farmers with choice and drive down costs. The government must support other similar efforts . . . .

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Read full, original post: Desi GM cotton seeds to compete with Monsanto

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-May-7-2026-12_32_36-PM
Viewpoint: The state of U.S. vaccine policy? Dismal nationally, but some states are stepping up.
Screenshot-2026-04-13-at-1.39.26-PM
Viewpoint: ‘Safer for children?’ Stonyfield yogurt under fire for deceptive organic marketing
Screenshot-2026-04-22-at-10.46.29-AM
Viewpoint: How to counter science disinformation? Science journalist offers 12 practical tips
ChatGPT-Image-May-7-2026-12_16_37-PM-2
Viewpoint: Are cancer rates ‘skyrocketing’ as RFK, Jr. and MAHA claim? The evidence says mostly the opposite
the magic of mRNA
Viewpoint: Anti-vax fake ‘turbo cancer’ claims threaten cancer treatment breakthroughs
ChatGPT-Image-May-7-2026-01_23_27-PM-2
Viewpoint: Will AI democratize personalized cancer treatment or fuel medical misinformation?
Defense_Secretary_Ash_Carter_tours_the_Microsoft_Cybercrime_Center_in_Seattle_March_3_2016
How criminals are using AI to target social media users and steal their money and confidential data
artificial intelligence brain think illustration md
Viewpoint — Digital gods and human extinction: Will we be the first species ever to design our own descendants?
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Food—health harming industries or life-saving innovators?
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
RFKjr-Tech-Vax-Misinfo
As U.S. officials spread medical misinformation, scientists fact check online
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.